表紙
市場調查報告書

鼻竇炎治療藥的臨床試驗:2020前半期

Sinusitis Global Clinical Trials Review, H1, 2020

出版商 GlobalData 商品編碼 944035
出版日期 內容資訊 英文 563 Pages
訂單完成後即時交付
價格
鼻竇炎治療藥的臨床試驗:2020前半期 Sinusitis Global Clinical Trials Review, H1, 2020
出版日期: 2020年05月04日內容資訊: 英文 563 Pages
簡介

本報告提供2020年前半期全球各地所進行的鼻竇炎治療藥臨床試驗調查,依國別(G7和E7),各地區彙整主要國家所進行的臨床試驗數量和平均登記數,臨床實驗的各期,各端點狀況,臨床試驗贊助者等資訊。

報告概要

  • 全球性臨床試驗的概述
  • 各地區,國家(G7及E7),臨床實驗的進展,臨床實驗的階段,臨床試驗贊助者的類型,各端點狀況的臨床試驗相關之最高層級資料
  • 主要企業相關的全部臨床實驗(臨床實驗的標題,階段,進展)資訊
  • 尚未完成的臨床實驗(結束,中斷,中止)及其理由
  • 過去5年的登記的趨勢
  • 過去3個月的最新的新聞

目錄

報告的指導

調查範圍

各地區所進行的臨床試驗

  • 各國臨床試驗與平均登記數
  • 亞太地區臨床試驗數量前五名國家
  • 歐洲臨床試驗數量前五名國家
  • 北美臨床試驗數量最多的國家
  • 中東·非洲臨床試驗數量前五名國家
  • 南美臨床試驗數量前五名國家

G7各國的臨床試驗:耳鼻咽喉疾病治療藥臨床實驗中鼻竇炎治療藥所佔的比例

G7各國的各階段臨床試驗

G7各國臨床實驗各進展狀況的臨床試驗

E7各國的臨床試驗:耳鼻咽喉疾病治療藥臨床實驗中鼻竇炎治療藥所佔的比例

E7各國的各階段臨床試驗

的E7各國臨床實驗各進展狀況的臨床試驗

各階段的臨床試驗

  • 各階段進行中的實驗

臨床實驗各進展狀況臨床實驗

各端點狀況的臨床試驗

一定期間所招募的臨床實驗對象

各臨床試驗贊助者類型的臨床試驗

主要的臨床試驗贊助者

  • 鼻竇炎的參加治療藥物臨床實驗的主要企業

主要的醫藥品

臨床試驗簡介的概述

附錄

  • 簡稱
  • 定義
  • 調查手法
  • 2次調查
  • 關於GlobalData
  • 諮詢方式
  • 資料
目錄
Product Code: GDHC6206CTIDB

GlobalData's clinical trial report, "Sinusitis Global Clinical Trials Review, H1, 2020" provides an overview of Sinusitis Clinical trials scenario. This report provides top line data relating to the clinical trials on Sinusitis. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress trials (based on number of ongoing trials). GlobalData Clinical Trial Reports are generated using GlobalData's proprietary database - Pharma - Clinical trials database. Clinical trials are collated from 80+ different clinical trial registries, conferences, journals, news etc across the globe. Clinical trials database undergoes periodic update by dynamic process.

The report enhances the decision making capabilities and helps to create an effective counter strategies to gain competitive advantage.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

  • The report provides a snapshot of the global clinical trials landscape
  • Report provides top level data related to the clinical trials by Region, Country (G7 & E7), Trial Status, Trial Phase, Sponsor Type and End point status
  • The report reviews top companies involved and enlists all trials (Trial title, Phase, and Status) pertaining to the company
  • The report provides all the unaccomplished trials (Terminated, Suspended and Withdrawn) with reason for unaccomplishment
  • The Report provides enrollment trends for the past five years
  • Report provides latest news for the past three months

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Reasons to Buy

  • Assists in formulating key business strategies with regards to investment
  • Helps in identifying prominent locations for conducting clinical trials which saves time and cost
  • Provides top level analysis of Global Clinical Trials Market which helps in identifying key business opportunities
  • Supports understanding of trials count and enrollment trends by country in global therapeutics market
  • Aids in interpreting the success rates of clinical trials by providing a comparative scenario of completed and uncompleted (terminated, suspended or withdrawn) trials
  • Facilitates clinical trial assessment of the indication on a global, regional and country level

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Table of Contents

Report Guidance

GlobalData Clinical Trials Report Coverage

Clinical Trials by Region

  • Clinical Trials and Average Enrollment by Country
  • Top Five Countries Contributing to Clinical Trials in Asia-Pacific
  • Top Five Countries Contributing to Clinical Trials in Europe
  • Top Countries Contributing to Clinical Trials in North America
  • Top Five Countries Contributing to Clinical Trials in Middle East and Africa
  • Top Five Countries Contributing to Clinical Trials in Central and South America

Clinical Trials by G7 Countries: Proportion of Sinusitis to Ear Nose Throat Disorders Clinical Trials

Clinical Trials by Phase in G7 Countries

Clinical Trials in G7 Countries by Trial Status

Clinical Trials by E7 Countries: Proportion of Sinusitis to Ear Nose Throat Disorders Clinical Trials

Clinical Trials by Phase in E7 Countries

Clinical Trials in E7 Countries by Trial Status

Clinical Trials by Phase

  • In Progress Trials by Phase

Clinical Trials by Trial Status

Clinical Trials by End Point Status

Subjects Recruited Over a Period of Time

Clinical Trials by Sponsor Type

Prominent Sponsors

  • Top Companies Participating in Sinusitis Therapeutics Clinical Trials

Prominent Drugs

Clinical Trial Profile Snapshots

Appendix

  • Abbreviations
  • Definitions
  • Research Methodology
  • Secondary Research
  • About GlobalData
  • Contact Us
  • Source

List of Tables

List of Tables

  • Sinusitis Therapeutics, Global, Clinical Trials by Region, 2020*
  • Sinusitis Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2020*
  • Sinusitis Therapeutics, Global, Clinical Trials In Progress by Top Countries, 20

List of Figures

List of Figures

  • Sinusitis Therapeutics, Global, Clinical Trials by Region (%), 2020*
  • Sinusitis Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2020*
  • Sinusitis Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2020*
  • Sinusitis Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries (%), 2020*
  • Sinusitis Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2020*
  • Sinusitis Therapeutics Clinical Trials, North America, Top Countries (%), 2020*
  • Sinusitis Therapeutics Clinical Trials, Middle East and Africa, Top Five Countries (%), 2020*
  • Sinusitis Therapeutics Clinical Trials, Central and South America, Top Five Countries (%), 2020*
  • Proportion of Sinusitis to Ear Nose Throat Disorders Clinical Trials, G7 Countries (%), 2020*
  • Sinusitis Therapeutics, G7 Countries, Clinical Trials by Phase, 2020*
  • Sinusitis Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2020*
  • Proportion of Sinusitis to Ear Nose Throat Disorders Clinical Trials, E7 Countries (%), 2020*
  • Sinusitis Therapeutics, E7 Countries, Clinical Trials by Phase, 2020*
  • Sinusitis Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2020*
  • Sinusitis Therapeutics, Global, Clinical Trials by Phase (%), 2020*
  • Sinusitis Therapeutics, Global, Clinical Trials In Progress by Phase, 2020*
  • Sinusitis Therapeutics, Global, Clinical Trials by Trial Status, 2020*
  • Sinusitis Therapeutics Clinical Trials, Global, by End Point Status, 2020*
  • Sinusitis Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2015-2019
  • Sinusitis Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2020*
  • Sinusitis Therapeutics Clinical Trials, Global, Key Sponsors, 2020*
  • Sinusitis Therapeutics Clinical Trials, Global, Top Companies by Phase, 2020*
  • Sinusitis Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2020*
  • GlobalData Methodology